Clinical trials commence for melanoma in UK and USA
Tuesday, October 5th, 2010IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has entered clinical trials in the UK and USA. IMCgp100 is the first clinical candidate originating from Immunocore’s innovative ImmTAC technology platform and a new treatment could benefit many thousands of patients diagnosed with skin cancer each year.